Drug-Drug Interactions: Clinical Perspective
- 19 October 2001
- book chapter
- Published by Taylor & Francis
- p. 596-615
- https://doi.org/10.1201/b14003-18
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Assessment of the Quality and Quantity of Drug‐Drug Interaction Studies in Recent NDA Submissions: Study Design and Data Analysis IssuesThe Journal of Clinical Pharmacology, 1999
- Inhibition of P-Glycoprotein–Mediated Drug TransportCirculation, 1999
- Concentrations and effects of buspirone are considerably reduced by rifampicinBritish Journal of Clinical Pharmacology, 1998
- Systemic Antifungal AgentsDrug Safety, 1998
- Enhanced effect of triazolam with diltiazemBritish Journal of Clinical Pharmacology, 1997
- Cytochrome P450 EnzymesJournal of Clinical Psychopharmacology, 1996
- CisaprideDrug Safety, 1996
- Effect of Fluvoxamine on the Pharmacokinetics of Imipramine and Desipramine in Healthy SubjectsTherapeutic Drug Monitoring, 1993
- Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequencesJAMA, 1993
- Pharmacokinetics of the Penicillins in ManClinical Pharmacokinetics, 1976